Browse the latest research summaries in the field of pain management for spinal cord injury patients and caregivers.
Showing 121-130 of 682 results
Biomedicines, 2023 • May 26, 2023
The study evaluated the anti-neuropathic activity of COR167, a novel selective CB2 agonist, in a preclinical model of peripheral neuropathy (SNI). Oral administration of COR167 reduced neuropathic pai...
KEY FINDING: Oral COR167 attenuated mechanical allodynia and thermal hyperalgesia in a dose-dependent manner after acute and repeated administration, without tolerance induction.
PLOS ONE, 2023 • July 13, 2023
The study investigates the neuroprotective effects of emodin on chronic constriction injury (CCI)-induced neuropathic pain (NP) in rats, focusing on the PPAR-γ pathway. Emodin treatment alleviated pai...
KEY FINDING: Emodin elevated response latency and delayed the onset of mechanical hyperalgesia in rats with CCI on days 7, 14, and 21.
The Journal of Neuroscience, 2023 • August 2, 2023
The study investigates the role of mGluR5, a glutamate receptor, in opioid-induced hyperalgesia and tolerance. It reveals that repeated opioid treatment promotes mGluR5 trafficking from DRG neurons to...
KEY FINDING: Repeated opioid treatment reduces mGluR5 protein levels in the DRG but increases them in the spinal cord, suggesting trafficking from DRG to spinal cord.
The Journal of Neuroscience, 2023 • August 2, 2023
This study investigates the mechanisms underlying decreased PVIN output in neuropathic pain using computational and experimental approaches. The study identifies a calcium-dependent mechanism involvin...
KEY FINDING: Nerve injury induces a change in PVIN firing patterns from tonic to adaptive in male mice.
Molecular Pain, 2023 • January 1, 2023
The study investigates the impact of urolithin A (UA) on neuropathic pain (NP) in mice, with a focus on mitophagy. The research demonstrates that UA activates mitophagy, mediated by PTEN-induced kinas...
KEY FINDING: Autophagy flow is blocked in the spinal dorsal horn of mice with chronic constriction injury (CCI), indicating impaired cellular cleaning processes during neuropathic pain.
CNS Neurosci Ther, 2023 • January 19, 2023
This study demonstrates that photobiomodulation (PBM) can alleviate neuropathic pain (NP) after spinal cord injury (SCI) in rats. PBM treatment led to improvements in pain-related behaviors and promot...
KEY FINDING: PBM therapy improves neuropathic pain behaviors after spinal cord injury in rats.
Pharmaceuticals, 2023 • July 19, 2023
This study evaluates the analgesic effects of mirogabalin in a mouse model of neuropathic pain induced by chronic constriction injury (CCI) of the sciatic nerve. The results indicate that mirogabalin ...
KEY FINDING: A single dose of mirogabalin is more effective than pregabalin in reducing tactile hypersensitivity in mice with nerve injury.
Neuroscience, 2023 • September 1, 2023
This study examined whether peripherally restricted KOR agonists can attenuate pain hypersensitivity in mice subjected to a contusive T10 SCI. Systemic administration of ICI-204448 achieved SCI pain i...
KEY FINDING: Systemic administration of ICI-204448 and asimadoline reduced below-level pain hypersensitivity in SCI mice. However, high-dose asimadoline adversely affected the exploratory performance of SCI mice and caused aversion.
Acta Neurochirurgica, 2023 • August 1, 2023
Herein, we report on a rare case of multiple and recurring intradural spinal arachnoid cysts (SACs) causing severe spinal cord compression and neuropathic radicular pain, in a 35-year-old female with ...
KEY FINDING: Multiple intradural SACs are rare, with only six cases being reported in the literature, including the one hereby presented.
Neurosci Lett, 2023 • September 25, 2023
This study investigates the effects of pramipexole and dexpramipexole on chronic allodynia and cytokine expression in mice with sciatic nerve damage. The researchers hypothesized that both compounds w...
KEY FINDING: Both pramipexole and dexpramipexole significantly reduced allodynia in mice within one hour of intravenous injection, although the effect was temporary, with allodynia returning after 24 hours.